AI assistant
Sending…
HALLIBURTON CO — Director's Dealing 2023
Mar 6, 2023
30269_dirs_2023-03-06_ed95ae54-fa47-413b-bced-79c02e38f4b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2023-03-02
Reporting Person: Carre Eric (EVP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-02 | Common Stock | F | 43204 | $37.18 | Disposed | 194766.842 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock | $31.44 | 2028-12-05 | Common Stock (50100) | 50100 | Direct |
| Option to Buy Common Stock | $43.38 | 2027-12-06 | Common Stock (34425) | 34425 | Direct |
| Option to Buy Common Stock | $53.54 | 2026-12-07 | Common Stock (30100) | 30100 | Direct |
| Option to Buy Common Stock | $34.48 | 2026-01-04 | Common Stock (9534) | 9534 | Direct |
| Option to Buy Common Stock | $39.49 | 2025-01-02 | Common Stock (24750) | 24750 | Direct |
| Option to Buy Common Stock | $50.01 | 2024-01-02 | Common Stock (8300) | 8300 | Direct |
Footnotes
F1: Shares transferred to Halliburton Company for payment for federal tax withholding obligations issued under the Halliburton Company Performance Unit Program, as required by the award agreement.
F2: The Performance Unit shares were issued on February 27, 2023. The closing price of Halliburton Company's Common Stock on the New York Stock Exchange on February 27, 2023 was $37.18.
More from HALLIBURTON CO
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 30